Functional interaction of transcriptional regulators in endocrine lineage specification
内分泌谱系规范中转录调节因子的功能相互作用
基本信息
- 批准号:10577702
- 负责人:
- 金额:$ 75.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalATAC-seqBeta CellBiophysicsC-terminalCell CycleCell Cycle ProgressionCell LineCell TherapyCell physiologyChromatinCompensationComplexConsensusDataDevelopmentDiabetes MellitusDiseaseEndocrineEnhancersEpigenetic ProcessExhibitsFailureGene Expression RegulationGenesGeneticGenetic TranscriptionGlucoseGrowthHeterozygoteHumanIn VitroInterventionIslets of LangerhansMediatingMicroscopyMolecularMolecular ConformationMusMutagenesisMutateMutationNon-Insulin-Dependent Diabetes MellitusOrgan SizeOrganogenesisPancreasPathway interactionsPhasePhenotypePhosphorylation SitePlayPost-Translational Protein ProcessingProliferatingPropertyProtein RegionProteinsPublishingRegulationResolutionRoleSiteSpecific qualifier valueStimulusStructureStructure of beta Cell of isletTechniquesTestingTherapeuticUbiquitinationWorkdesignendocrine pancreas developmentflexibilitygenome editinghomeodomainhuman embryonic stem cellhuman pluripotent stem cellin vivoinsulin promoter factor 1insulin secretionintermolecular interactionisletislet stem cellsmembermimeticsmouse modelmultiple omicsnoveloverexpressionpancreas developmentpermissivenesspostnatalprediction algorithmpreventprogenitorprogramspromoterprotein protein interactionresponsesingle nucleus RNA-sequencingsingle-cell RNA sequencingstem cell differentiationtranscription factorubiquitin-protein ligase
项目摘要
SUMMARY
Reduction in functional insulin-secreting β cells underlies the progression of all forms of diabetes, underscoring
the translational relevance of deciphering molecular pathways regulating the formation, growth, and function of
β cells. The transcriptional networks critical for the proper development, differentiation, and expansion of β cells
work through islet enhancers, super enhancers, and active promoters that form 3D hubs. The homeodomain
transcription factor Pdx1 is a critical member of the β-cell transcriptional network during development and in
postnatal β-cell function. Pdx1 is mutated in monogenic forms of human diabetes and plays critical roles in early
pancreas specification, regulation of organ size, and in β-cell formation, proliferation, and identity. Our
preliminary data reveal that developing β cells exhibit altered subnuclear localization and reduced levels of Pdx1
protein as they advance through the cell cycle. Further, ectopically elevated levels of Pdx1 prevent cell cycle
progression, suggesting that dynamic regulation of expression is required for effective β-cell expansion. We
identify an intrinsically disordered protein region (IDPR) in the Pdx1 C-terminus (aa 207-223). IDPRs, commonly
found within transcription factors, lack fixed secondary structure and are amenable to flexible conformations and
phase separation. IDPRs promote protein-protein interactions and transcriptional hub formation at super
enhancers necessary for coordinated gene regulation. We have found that the Pdx1 C-terminus mediates
interaction with the one cut homeodomain transcription factor Oc1 in multipotent pancreatic progenitor cells to
establish the endocrine gene program, with long-term impact on postnatal islet function and β-cell compensation.
We previously identified the E3 ubiquitin ligase substrate adaptor SPOP as a PDX1 C-terminus partner (via
aa224-238) that mediates ubiquitination and proteasomal degradation of PDX1. Our preliminary data suggest
that SPOP and Oc1 compete for interaction with the Pdx1 C-terminus and that Oc1 protects Pdx1 from SPOP-
mediated degradation. Notably, the C-terminus harbors several diabetes-associated human mutations, one of
which we recently found disrupts the PDX1/SPOP interaction. Thus, we hypothesize that PDX1/OC1
interactions, in part mediated by their IDPRs, regulate Pdx1 stability, cell cycle progression, and pancreatic
endocrine differentiation. This hypothesis will be tested in 3 Aims: (1) To determine the mechanisms whereby
Pdx1 and Oc1 cooperate to establish a chromatin landscape permissive for endocrine differentiation and
proliferation; (2) To define the roles of the Pdx1 and Oc1 IDPRs in protein-protein interaction and pancreas
development; and (3) To define the molecular mechanisms by which the Pdx1 C-terminal domain regulates
protein stability and function during pancreas organogenesis and endocrine differentiation. The impact of human
diabetes-associated mutations will be investigated in this context. Our studies will determine a novel and
cohesive role for unstudied structural features of the Pdx1 C-terminus in β-cell development. Results of our
studies will inform therapeutic efforts to optimize β-cell expansion for cell-based therapies.
概括
功能性胰岛素分泌β细胞的减少是所有形式的糖尿病的进展,强调
解密分子途径的翻译相关性调节了调节的形成,生长和功能
β细胞。转录网络对于β细胞的正确发育,分化和扩展至关重要
通过形成3D枢纽的胰岛增强剂,超级增强剂和主动启动子进行工作。同源域
转录因子PDX1是开发过程中β细胞转录网络的关键成员
产后β细胞功能。 PDX1以人类糖尿病的单基因形式突变,并在早期起着关键作用
胰腺规范,器官大小的调节以及β细胞形成,增殖和身份。我们的
初步数据表明,开发β细胞暴露于下核定位改变和PDX1的水平降低
蛋白质在整个细胞周期中前进时。此外,升高的PDX1水平预防细胞周期
进展,表明表达动态调节是有效的β细胞扩张所必需的。我们
识别PDX1 C末端(AA 207-223)中本质上无序的蛋白质区域(IDPR)。 IDPR,通常
在转录因素中发现,缺乏固定的二级结构,并且可以适合柔性构象和
相分离。 IDPR促进了超级蛋白质 - 蛋白质相互作用和转录中心的形成
协调基因调控所需的增强子。我们发现PDX1 C末端培养基
与多核胰腺祖细胞中的一个切割同源域转录因子OC1相互作用
建立内分泌基因程序,对产后功能和β细胞补偿有长期影响。
我们以前以前将E3泛素连接酶底物适配器SPOP鉴定为PDX1 C末端合作伙伴(通过
AA224-238)介导PDX1的泛素化和蛋白酶体降解。我们的初步数据暗示
该SPOP和OC1竞争与PDX1 C末端的相互作用,并且OC1保护PDX1免受Spop-
介导的降解。值得注意的是,C末端具有几个糖尿病相关的人类突变,其中之一
我们最近发现这破坏了PDX1/SPOP相互作用。那就是我们假设PDX1/OC1
相互作用部分由IDPR介导的部分调节PDX1稳定性,细胞周期进程和胰腺
内分泌区分。该假设将以3个目的进行检验:(1)确定机制
PDX1和OC1合作以建立允许内分泌区分的染色质景观和
增殖; (2)定义PDX1和OC1 IDPR在蛋白质 - 蛋白质相互作用和胰腺中的作用
发展; (3)定义PDX1 C末端结构域调节的分子机制
胰腺器官发生和内分泌分化过程中的蛋白质稳定性和功能。人类的影响
在这种情况下,将研究与糖尿病相关的突变。我们的研究将决定一部小说,
PDX1 C末端在β细胞发育中未研究的结构特征的内聚作用。我们的结果
研究将为优化基于细胞的疗法的β细胞扩展的治疗努力提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maureen A Gannon其他文献
Maureen A Gannon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maureen A Gannon', 18)}}的其他基金
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
- 批准号:
10360796 - 财政年份:2022
- 资助金额:
$ 75.47万 - 项目类别:
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
调节前列腺素 E2 受体活性以改善胰岛功能
- 批准号:
10611349 - 财政年份:2022
- 资助金额:
$ 75.47万 - 项目类别:
Manipulating islet GPCR activity to promote beta cell proliferation and survival
操纵胰岛 GPCR 活性促进 β 细胞增殖和存活
- 批准号:
10453748 - 财政年份:2019
- 资助金额:
$ 75.47万 - 项目类别:
Manipulating islet GPCR activity to promote beta cell proliferation and survival
操纵胰岛 GPCR 活性促进 β 细胞增殖和存活
- 批准号:
10022326 - 财政年份:2019
- 资助金额:
$ 75.47万 - 项目类别:
Manipulating islet GPCR activity to promote beta cell proliferation and survival
操纵胰岛 GPCR 活性促进 β 细胞增殖和存活
- 批准号:
10219238 - 财政年份:2019
- 资助金额:
$ 75.47万 - 项目类别:
Pathways regulating adult pancreatic beta cell replication
调节成人胰腺β细胞复制的途径
- 批准号:
9241554 - 财政年份:2016
- 资助金额:
$ 75.47万 - 项目类别:
Formation and maturation of endocrine pancreas progenitors
内分泌胰腺祖细胞的形成和成熟
- 批准号:
9197982 - 财政年份:2015
- 资助金额:
$ 75.47万 - 项目类别:
Formation and maturation of endocrine pancreas progenitors
内分泌胰腺祖细胞的形成和成熟
- 批准号:
9056074 - 财政年份:2015
- 资助金额:
$ 75.47万 - 项目类别:
Regulation of adult pancreatic beta cell replication
成人胰腺β细胞复制的调节
- 批准号:
8140822 - 财政年份:2011
- 资助金额:
$ 75.47万 - 项目类别:
Regulation of adult pancreatic beta cell replication
成人胰腺β细胞复制的调节
- 批准号:
8244927 - 财政年份:2011
- 资助金额:
$ 75.47万 - 项目类别:
相似国自然基金
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:82260745
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:32100438
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Tools for reversible short-term degradation of TCF-1 to address its molecular functions
用于 TCF-1 可逆短期降解以解决其分子功能的工具
- 批准号:
10647571 - 财政年份:2023
- 资助金额:
$ 75.47万 - 项目类别:
Elucidating the FOXF1 gene regulatory network in human alveologenesis
阐明人类肺泡发生中的 FOXF1 基因调控网络
- 批准号:
10558865 - 财政年份:2023
- 资助金额:
$ 75.47万 - 项目类别:
Mapping heritable chromatin loop variants with allele-specific Hi-C analysis
通过等位基因特异性 Hi-C 分析绘制可遗传的染色质环变体图谱
- 批准号:
10583721 - 财政年份:2023
- 资助金额:
$ 75.47万 - 项目类别:
Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response
剖析 2 型糖尿病相关变异和效应基因在胰岛内质网应激反应中的作用
- 批准号:
10464542 - 财政年份:2022
- 资助金额:
$ 75.47万 - 项目类别:
Dissecting the roles of type 2 diabetes-associated variants and effector genes in islet endoplasmic reticulum stress response
剖析 2 型糖尿病相关变异和效应基因在胰岛内质网应激反应中的作用
- 批准号:
10582540 - 财政年份:2022
- 资助金额:
$ 75.47万 - 项目类别: